EANS-Adhoc: LifeWatch to launch world's first-of-its-kind healthcare solution Smartphone offering multiple embedded medical sensors and wellness-related applications as well as services (with document

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

New Products/LifeWatch AG

07.06.2012

First-ever live demonstration in Zurich on June 27, 2012

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE), the leading wireless cardiac monitoring service and
home sleep test provider in the U.S., announces today the launch of
the world's first-of-its-kind healthcare solution Smartphone,
allowing consumers self-operation of a wide range of highly valuable
embedded medical sensors as well as wellness-related applications and
cloud-based services. With this new technology LifeWatch will be able
to expand outside its core markets, targeting new customer segments,
service offerings and geographies. A comprehensive presentation and
live demonstration of the solution will be given in Zurich on June
27, 2012.

You will find a PDF-version of this press release and a registration
form at the end of this message.

LifeWatch has defined a number of strategic initiatives for future
growth. LifeWatch's announcement today will allow the company to
diverse into new services and geographies. This first-of-its-kind
solution offers different layers of self-operated medical sensors,
wellness-related applications as well as cloud-based services. The
modular offering is targeted at health- and wellbeing-conscious
consumers world-wide.

With this unique solution, for the first time, healthcare consumers
and patients will be able to manage their medical condition and
well-being anywhere anytime. It will empower patients and will assist
in providing better care for lower costs, thus improving the use of
health resources.

Emerging mobile health markets

Recent market developments have witnessed the emergence of
health-dedicated mobile technologies in both developed and emerging
countries. The latest mobile health market research by Frost &
Sullivan indicated a market size of USD 1.5 billion in 2011 in the
U.S. alone.

LifeWatch hired the leading management consulting firm McKinsey &
Company to provide a full and complete Go-to-Market Analysis based on
which it intends to launch the healthcare solution Smartphone
world-wide.

LifeWatch: Transforming the mobile health market

Do you want to learn more about LifeWatch's latest breakthrough
technology? And: Find out about the latest trends in mobile health
markets? Join us for a live demonstration of the world's
first-of-its-kind healthcare solution Smartphone in Zurich on June
27, 2012. Use the attached form to register now.

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac
monitoring service provider, and manufacturer of telecardiology
products. LifeWatch is also introducing a new program for Home Sleep
Testing of Obstructive Sleep Apnea (OSA) patients under the brand
name NiteWatch. For additional information, please visit
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue,""anticipate,"
"intend," "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/FuF7JANZ
http://resources.euroadhoc.com/us/2dI7DlCg

Further inquiry note:
Sensus Investor and Public Relations GmbH, Zürich:
Tel+41 433665511 | Fax+41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/FuF7JANZ
http://resources.euroadhoc.com/us/2dI7DlCg

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English